• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Alvocidib reversible enzyme inhibition

The individual immunodeficiency virus type I (HIV-1) transactivator protein Tat can

June 3, 2019 by Katherine Lewis Leave a Comment

The individual immunodeficiency virus type I (HIV-1) transactivator protein Tat can be an unusual transcriptional activator that’s considered to act solely by promoting RNA polymerase II processivity. RNA polymerase II (course II genes) could be categorized into two groupings. Initial, general (or simple) transcription elements (GTFs) are essential and can end up being enough for … [Read more…]

Posted in: Blogging Tagged: Alvocidib reversible enzyme inhibition, Mouse monoclonal to GSK3 alpha

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by